Prostate cancer: what does the future hold? CPD

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

Info

You must login to watch this lecture.

x Mobile version: slides + audio only
-15s 00:00 / 19:03 +15s
Minimise video

Professor Nick James talks about the future of prostate cancer. Professor James covers the STAMPEDE trial, the advantages in using mCRPC, and the non-survival benefits of docetaxel. 

This lecture was filmed at 'prostate cancer: what does the future hold?' meeting at the Royal Society of Medicine in London.

Date of lecture: 12th of October 2016

Length: 00:19:03

Tips about RSM Videos

  • This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
  • This video is linked to a CPD credit. Both RSM members and non-members must login before watching the video to be able to claim a CPD credit.
  • Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
  • Click on the Chapters tab to view different parts of the video.

Error

You must login to watch this lecture.

Error

You must login to watch this lecture.

27:21

Steve Dewar, Director of Research and Innovation at Marie Curie Cancer Care. 

Archived View
31:15

Professor Karol Sikora, Medical Director, CancerPartnersUK.

Free Archived View
32:47

Harpal Kumar, CEO, Cancer Research UK

Free Audio View
53:36

Professor Robin Williamson, Immediate Past-President, RSM.

Free View
24:38

Dr Simon Hughes, Consultant Oncologist, Guys and St Thomas' Hospitals.

CPD View
51:48

Dr Carlo Croce, Comprehensive Cancer Center, USA.

CPD View
28:14

Piers Gough (Architect) & Mandy McMahan (Clinical Psychologist), Maggie's Cancer Centres. 

Free View
28:33

Assistant Professor John Qualter, Langone Medical Centre, New York. 

Free View
25:21

Helen Lyndon, Nurse Consultant, Cornwall and Isles of Scilly Primary Care Trust.

CPD View

Error

You must login to watch this lecture.